|
Sign In to gain access to subscriptions and/or personal tools.
|
Treatment of Delirium in Older Adults with Quetiapine
Kye Y. Kim, MD
Salem Veterans Affairs Medical Center, Department of Psychiatric Medicine, School of Medicine, University of Virginia
Geoffrey M. Bader, MD
Salem Veterans Affairs Medical Center, Department of Psychiatric Medicine, School of Medicine, University of Virginia
Victor Kotlyar, MD
Institute of Living, Hartford, CT
Debra Gropper, PharmD
Perry Point Veterans Affairs Medical Center, Perry Point, MD
Delirium is a neuropsychiatric syndrome characterized by impairment of consciousness, changes in cognition, or perceptual disturbances. In addition, delirium is often accompanied by delusions, hallucinations, and agitation. In this study, 12 older patients with delirium were treated for neuropsychiatric symptoms with quetiapine. The mean duration for stabilization was 5.91 ± 2.22 days, and the mean dose was 93.75 ± 23.31 mg/day. None of the 12 patients developed extrapyramidal symptoms. There were significant improvements on all measures used in this study. Interestingly, the Delirium Rating Scale scores along with scores of the Mini-Mental State Examination and Clock Drawing Test continued to improve throughout the 3-month study period. In our study, we found that quetiapine was a safe and effective treatment in hospitalized older patients with delirium. (J Geriatr Psychiatry Neurol 2003; 16:29-31)
Key Words: delirium older adults quetiapine behavioral symptoms
Journal of Geriatric Psychiatry and Neurology, Vol. 16, No. 1,
29-31 (2003)
DOI: 10.1177/0891988702250533

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
W. Breitbart and Y. Alici
Agitation and Delirium at the End of Life: "We Couldn't Manage Him"
JAMA,
December 24, 2008;
300(24):
2898 - 2910.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. N. Zama, W. K. Maynard, and M. P. Davis
Clocking Delirium: The Value of the Clock Drawing Test with Case Illustrations
American Journal of Hospice and Palliative Medicine,
October 1, 2008;
25(5):
385 - 388.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Laible and T. Johnson
Delirium in the Hospitalized Patient: A Primer for the Pharmacist Clinician
Journal of Pharmacy Practice,
October 1, 2007;
20(5):
368 - 372.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Lacasse, M. M Perreault, and D. R Williamson
Systematic Review of Antipsychotics for the Treatment of Hospital-Associated Delirium in Medically or Surgically Ill Patients
Ann. Pharmacother.,
November 1, 2006;
40(11):
1966 - 1973.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Straker, P. A. Shapiro, and P. R. Muskin
Aripiprazole in the Treatment of Delirium
Psychosomatics,
October 1, 2006;
47(5):
385 - 391.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Adamis, C. Morrison, A. Treloar, A. J. D. Macdonald, and F. C. Martin
The Performance of the Clock Drawing Test in Elderly Medical Inpatients: Does It Have Utility in the Identification of Delirium?
J Geriatr Psychiatry Neurol,
September 1, 2005;
18(3):
129 - 133.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-S. Han and Y.-K. Kim
A Double-Blind Trial of Risperidone and Haloperidol for the Treatment of Delirium
Psychosomatics,
August 1, 2004;
45(4):
297 - 301.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|